|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-9-24
|
|
pubmed:abstractText |
We tested the hypothesis that individualized dosing of amantadine hydrochloride, based upon a patient's creatinine clearance, would maintain efficacy against influenza A infection while reducing adverse reactions to the drug.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1198-581X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
119-22
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14506511-Aged,
pubmed-meshheading:14506511-Aged, 80 and over,
pubmed-meshheading:14506511-Amantadine,
pubmed-meshheading:14506511-Antiviral Agents,
pubmed-meshheading:14506511-Disease Outbreaks,
pubmed-meshheading:14506511-Female,
pubmed-meshheading:14506511-Humans,
pubmed-meshheading:14506511-Influenza, Human,
pubmed-meshheading:14506511-Institutionalization,
pubmed-meshheading:14506511-Kidney,
pubmed-meshheading:14506511-Kidney Function Tests,
pubmed-meshheading:14506511-Male,
pubmed-meshheading:14506511-Nursing Homes
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
An amantadine hydrochloride dosing program adjusted for renal function during an influenza outbreak in elderly institutionalized patients.
|
|
pubmed:affiliation |
City of Hamilton-Social and Public Health Services Department, Hamilton, Ontario, Canada. fkolbe@city.toronto.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
